Author:
Nishikori Tomohiro,Irie Kaoru,Suganuma Taiyo,Ozaki Makoto,Yoshioka Toshimasa
Reference23 articles.
1. Pharmacological profile of SB203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function;Badger;J. Pharmacol. Exp. Ther.,1996
2. SB203580 inhibits p38 mitogen-activated protein kinase, nitric oxide production, and inducible nitric oxide synthase in bovine cartilage-derived chondrocytes;Badger;J. Immunol.,1998
3. Effect of the p38 kinase inhibitor, SB203580, on allergic airway inflammation in the rat;Escott;Br. J. Pharmacol.,2000
4. Prostaglandin E2 regulates the level and stability of cyclooxygenase-2 mRNA through activation of p38 mitogen-activated protein kinase in interleukin-1β-treated human synovial fibroblasts;Faour;J. Biol. Chem.,2001
5. Possible role of nitric oxide in 5-hydroxytryptamine-induced increase in vascular permeability in mouse skin;Fujii;Naunyn-Schmiedeberg's Arch. Pharmacol.,1994
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献